Table 1: Clinical and laboratory data.
N° |
Age |
Sex |
DIAGNOSIS |
Symptoms1 (days) |
Hosp2 (days) |
Ferritin3 (ng/mL) |
D-dimer4 (mg/dL) |
COMORBIDITY |
||
MT5 |
RT6 |
OTHER7 |
||||||||
1 |
72 |
M |
POS |
NEG |
X |
8 |
6 |
1542 |
0.65 |
NO |
2 |
56 |
M |
POS |
NEG |
X |
2 |
2 |
217 |
0 |
NO |
3 |
50 |
M |
POS |
ND |
X |
11 |
12 |
4.49 |
2.67 |
RI |
4 |
31 |
M |
ND |
POS IgM |
X |
2 |
2 |
ND |
0.78 |
B-cell leukemia |
5 |
72 |
M |
POS |
ND |
X |
7 |
2 |
942.4 |
> 4.6 |
DM |
6 |
72 |
M |
ND |
POS IgG |
X |
5 |
5 |
1433 |
35.6 |
HT |
7 |
55 |
M |
POS |
ND |
X |
5 |
18 |
|
3.36 |
HT, Obesity |
8 |
78 |
M |
ND |
ND |
X |
5 |
5 |
870 |
0.79 |
NO |
9 |
69 |
M |
ND |
ND |
X |
4 |
5 |
11500 |
1.52 |
NO |
10 |
68 |
M |
ND |
POS IgG/IgM |
X |
10 |
4 |
1132.1 |
4.31 |
HT, Obesity |
11 |
55 |
M |
POS |
NEG |
X |
NR |
8 |
416 |
0.24 |
NO |
12 |
65 |
M |
ND |
POS IgG/IgM |
X |
13 |
5 |
9326 |
1.3 |
Asma |
13 |
78 |
M |
ND |
POS IgG/IgM |
X |
NR |
9 |
705 |
1.25 |
DM |
14 |
72 |
M |
ND |
NEG |
X |
8 |
19 |
10140 |
2.52 |
HT |
15 |
51 |
F |
POS |
ND |
X |
6 |
16 |
818.2 |
0.8 |
NO |
16 |
65 |
M |
POS |
NEG |
X |
10 |
16 |
1225 |
0.16 |
HT, Obesity, MI |
17 |
91 |
M |
POS |
POS IgG/IgM |
X |
3 |
8 |
770 |
31.9 |
NO |
18 |
63 |
M |
ND |
POS IgG/IgM |
X |
15 |
10 |
942 |
7.47 |
NO |
1Days of symptomatology, before admission; 2Days in hospital, before decease; 3Maximum value of Ferritin; 4Maximum value of D-Dimer; 5Molecular test; 6Rapid Test; 7Computed tomography and/or chest X-ray of atypical pneumonia; ND: Not Done; POS: Positive; NEG: Negative; NR: Not Referred; RI: Renal Insufficiency; DM: Diabetes Mellitus; HT: Hypertension; MI: Myocardial Infarction. Normal values of Ferritin: 12 - 300 ng/mL (men); 12 - 150 ng/mL (women). Normal values of D-dimer: < 0.5 mg/dL. Rapid Test: COVID-19 IgM/IgG Combo SD Biocensor®. Molecular test.